Cellmid Share Price and Company Fundamentals



Price
$0.066
Change
-0.002 (-2.941%)
52 week
0.065 - 0.385

Last traded: Today at 3:21 AM

Cellmid Limited, a life sciences company, researches, develops, and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers midkine, a driver and modulator of inflammatory diseases, including chronic inflammatory diseases and cancer; and focuses on blocking midkine, a protein for autoimmune disorders, chronic inflammation, osteoporosis, cardiovascular diseases, cancer, and neurodegenerative diseases. It also develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. In addition, the company sells SARS-CoV-2 antibody kits and PCR tests. It markets its products through retailers and wholesalers, as well as through a direct-to-consumer e-commerce platform. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

1.12

Dividend yield

Beta

-1.43

Market cap

$11.75M

Enterprise value

$5.93M

Company profile

Primary activitiesDeveloper of products to treat various cancers and chronic inflammatory diseases
Industry / SectorBiotechnology / Healthcare
Websitehttp://www.cellmid.com.au
Mailing address55 Clarence Street Suite 204 Level 2 Sydney NSW 2000 Australia
Phone / Fax61 2 9221 6830 / 61 2 9221 8535
Share registryAUTOMIC REGISTRY SERVICES

Dividends

Cellmid does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Cellmid.

NameTitleAgeTotal Pay
Ms. Maria HalaszCEO, MD & Exec. Director549.82k
Mr. Koichiro KoikeManaging Director of Advangen Inc63303.67k
Mr. Matthew DudekGroup Financial Controller
Mr. Dominic BurgChief Operating Officer
Dr. Graham RobertsonHead of R&D
Ms. Trish FrelanGlobal Head of Marketing Advangen Pty Ltd
Mr. Lee Tamplin B.A.Company Sec.

Profitability and management effectiveness

Profit margin

-89.24%

Operating margin

-88.05%

Return on assets

-32.70%

Return on equity

-82.88%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Cellmid is 11.75M and its enterprise value is 5.93M. The enterprise value to revenue ratio of CDY is 0.90.

Companies similar to Cellmid (CDY)

Cellmid (ASX:CDY) Frequently Asked Questions

1. What is Cellmid's Stock Symbol?

Cellmid trades on ASX under the ticker symbol "CDY".

2. What is Cellmid's stock price today?

One share of CDY stock can currently be purchased for approximately $0.066.

3. How can I contact Cellmid?

Cellmid's mailing address is 55 Clarence Street Suite 204 Level 2 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9221 6830.

4. What is Cellmid's official website?

The official website of Cellmid is http://www.cellmid.com.au.

5. Which share registry manages Cellmid's stock?

Cellmid's stock is managed by AUTOMIC REGISTRY SERVICES.